Yang M - Search Results

1

Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ.

Yang M, Chen Z, Xiang S, Xia F, Tang W, Yao X, Zhou B. Yang M, et al. BMC Complement Med Ther. 2020 Dec 11;20(1):377. doi: 10.1186/s12906-020-03164-3. BMC Complement Med Ther. 2020. PMID: 33308192 Free PMC article.

2

Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury.

Xia F, Yao X, Tang W, Xiao C, Yang M, Zhou B. Xia F, et al. Among authors: yang m. Front Pharmacol. 2017 Feb 28;8:99. doi: 10.3389/fphar.2017.00099. eCollection 2017. Front Pharmacol. 2017. PMID: 28293193 Free PMC article.

3

Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.

Yao X, Xia F, Tang W, Xiao C, Yang M, Zhou B. Yao X, et al. Among authors: yang m. J Ethnopharmacol. 2018 Feb 15;212:208-215. doi: 10.1016/j.jep.2017.09.016. Epub 2017 Oct 13. J Ethnopharmacol. 2018. PMID: 29031784

4

Data for iTRAQ-based quantification of the effect of HuganQingzhi on non-alcoholic fatty liver disease in rats.

Yao X, Xia F, Tang W, Xiao C, Yang M, Zhou B. Yao X, et al. Among authors: yang m. Data Brief. 2017 Oct 16;15:612-614. doi: 10.1016/j.dib.2017.10.027. eCollection 2017 Dec. Data Brief. 2017. PMID: 29085877 Free PMC article.

5

[Effects of sera of rats fed with Huganqingzhi tablets on endoplasmic reticulum stress in a HepG2 cell model of nonalcoholic fatty liver disease].

Yang M, Chen Z, Xiao C, Tang W, Zhou B. Yang M, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2018 Nov 30;38(11):1277-1287. doi: 10.12122/j.issn.1673-4254.2018.11.01. Nan Fang Yi Ke Da Xue Xue Bao. 2018. PMID: 30514673 Free PMC article. Chinese.

6

Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.

Tang W, Yao X, Xia F, Yang M, Chen Z, Zhou B, Liu Q. Tang W, et al. Among authors: yang m. Oxid Med Cell Longev. 2018 Dec 23;2018:7261619. doi: 10.1155/2018/7261619. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30671174 Free PMC article.

7

Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways.

Yang M, Yao X, Xia F, Xiang S, Tang W, Zhou B. Yang M, et al. BMC Complement Med Ther. 2024 Jan 12;24(1):36. doi: 10.1186/s12906-024-04336-1. BMC Complement Med Ther. 2024. PMID: 38216941 Free PMC article.

8

Establishment of LC-MS/MS Methodology for the Determination of Rapamycin Concentration in Rat Whole Blood.

Yang Y, Yang M, Wang L, He L, Shi T. Yang Y, et al. Among authors: yang m. Comb Chem High Throughput Screen. 2024 Sep 3. doi: 10.2174/0113862073291189240819115228. Online ahead of print. Comb Chem High Throughput Screen. 2024. PMID: 39229993

9

Convergent Total Synthesis of Kalmanol.

Zhao R, Zhao X, Yang M. Zhao R, et al. Among authors: yang m. Angew Chem Int Ed Engl. 2024 Nov 27:e202420507. doi: 10.1002/anie.202420507. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 39601625

10

The Ameliorative Effect of Betulinic Acid on Oxidative Stress in Mice of Cyclophosphamide-Induced Liver Damage.

Huang Y, Ma C, Zhu L, Kong L, Huang C, Yang W, He J, Yang M, Huang L, Yuan L, Yi J. Huang Y, et al. Among authors: yang m. Environ Toxicol. 2024 Nov 27. doi: 10.1002/tox.24444. Online ahead of print. Environ Toxicol. 2024. PMID: 39601349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,554 results

Search Page

Filters